Potential Drug-drug Interactions Analysis in Children Out-patients with Bronchopneumonia Medication Prescriptions
Open Access
- 21 May 2020
- journal article
- Published by Universitas Muhammadiyah Palangkaraya in Borneo Journal of Pharmacy
- Vol. 3 (2), 79-83
- https://doi.org/10.33084/bjop.v3i2.1316
Abstract
Drug-drug interactions (DDIs) is defined as the alteration of efficacy and toxicity of some drugs in the presence of other drugs. In the treatments of bronchopneumonia in outpatient settings, there is a lack of documentation of DDIs. This study was aimed to observe the potential DDIs on the prescriptions of children with bronchopneumonia. An observational and cross-sectional study was conducted on outpatient children with bronchopneumonia prescriptions during 2017. Potential for DDI was identified by online drug interaction checkers. The potential DDI then classified based on its severity (minor, moderate, and major) and mechanism (pharmacokinetic and pharmacodynamic). Among 86 prescriptions analyzed, potential DDIs observed at 48.84% of it. Of that, there were 67 potential DDIs where 72.34% of it were categorized as moderate. The majority of potential DDIs was pharmacodynamic interaction (76.12%) with the most frequently involved drug pair was Ephedrine-Salbutamol (29.85%). Children outpatients with bronchopneumonia are at risk of potential DDIs, especially to minor and moderate potential DDIs. Prescriptions screening for potential DDIs followed by monitoring of therapeutical effects and associated adverse drug events will optimize patient safety.Keywords
This publication has 16 references indexed in Scilit:
- Potential drug-drug interactions among pneumonia patients: do these matter in clinical perspectives?BMC Pharmacology and Toxicology, 2019
- Potential drug-drug interactions in outpatient department of a tertiary care hospital in Pakistan: a cross-sectional studyBMC Health Services Research, 2018
- Hypokalemia: a clinical updateEndocrine Connections, 2018
- Effect of Ventolin on QTc in children with respiratory distressJournal of Cardiovascular and Thoracic Research, 2016
- Hospital admissions/visits associated with drug–drug interactions: a systematic review and meta‐analysisPharmacoepidemiology and Drug Safety, 2014
- A study on drug–drug interactions through prescription analysis in a South Indian teaching hospitalTherapeutic Advances in Drug Safety, 2013
- Over-the-counter (OTC) medications to reduce cough as an adjunct to antibiotics for acute pneumonia in children and adultsPublished by Wiley ,2012
- British Thoracic Society guidelines for the management of community acquired pneumonia in children: update 2011Thorax, 2011
- TheophyllinePharmaceuticals, 2010
- Prevalence of Polypharmacy, Polyherbacy, Nutritional Supplement Use and Potential Product Interactions among Older Adults Living on the United States-Mexico BorderDrugs & Aging, 2009